Public Market Listing
SUVENNSE
Live quotes, historical charts, and market capitalization for Suven Life Sciences are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
2Total Assets
0Approved
1Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Serotonin 5-HT6 receptorSmall molecule | Alzheimer's Disease | |
| Phase 2 | Alpha4beta2 nicotinic acetylcholine receptorSmall molecule | Major Depressive Disorder |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (1)
December 2026 (1)
Est. primary completion 2026-12 · NCT05397639 · CT.gov ↗